Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin-7 receptor subunit alpha (IL-7Rα), also known as CD127, is a type I cytokine receptor essential for the development and homeostasis of T and B lymphocytes. It forms a heterodimer with the common gamma chain (γc/CD132) to create the functional IL-7 receptor. Upon binding of IL-7, the receptor complex activates intracellular signaling pathways, primarily the JAK/STAT pathway, leading to cell survival and proliferation. IL-7Rα also participates in the TSLP receptor complex and is implicated in various diseases, including SCID, autoimmune disorders, and leukemia.
Ligand binding (IL-7 or TSLP) to the IL-7Rα/γc heterodimer activates the JAK/STAT signaling pathway, promoting cell survival and proliferation. Receptor endocytosis regulates signaling duration and receptor availability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin-7 Receptor Subunit Alpha (IL-7Rα).